Syra Health Corp. (NASDAQ:SYRA – Get Free Report) saw a significant drop in short interest during the month of February. As of February 28th, there was short interest totalling 870,700 shares, a drop of 43.8% from the February 13th total of 1,550,000 shares. Based on an average daily trading volume, of 2,100,000 shares, the short-interest ratio is currently 0.4 days. Currently, 8.9% of the shares of the company are short sold.
Syra Health Stock Performance
NASDAQ:SYRA traded down $0.02 during mid-day trading on Friday, hitting $0.34. 138,583 shares of the stock were exchanged, compared to its average volume of 761,196. The stock has a market capitalization of $3.85 million, a price-to-earnings ratio of -0.52 and a beta of 3.20. The firm’s 50-day simple moving average is $0.44 and its 200 day simple moving average is $0.47. Syra Health has a fifty-two week low of $0.32 and a fifty-two week high of $2.27.
Syra Health (NASDAQ:SYRA – Get Free Report) last posted its quarterly earnings data on Tuesday, March 11th. The company reported ($0.05) EPS for the quarter. Syra Health had a negative return on equity of 131.94% and a negative net margin of 54.90%. The company had revenue of $2.00 million for the quarter, compared to the consensus estimate of $2.01 million. On average, analysts predict that Syra Health will post -0.53 EPS for the current fiscal year.
Syra Health Company Profile
Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions.
Read More
- Five stocks we like better than Syra Health
- Overbought Stocks Explained: Should You Trade Them?
- How to Build the Ultimate Everything ETF Portfolio
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Dividend Capture Strategy: What You Need to Know
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Syra Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syra Health and related companies with MarketBeat.com's FREE daily email newsletter.